Skip to main content

G3 Therapeutics

  • About us
  • Pipeline
  • Our platform
    • Pillar 1
    • Pillar 2
    • Pillar 3
  • Partners & Investors
  • News
    • Publications
  • Contact

News

G3T's Latest News, Events and Articles

Type
Global Genomics Group (“G3″) Appoints Harry “Chip” Davis, Zetia® Inventor, As Chief Drug Development Officer

Global Genomics Group (“G3″) Appoints Harry “Chip” Davis, Zetia® Inventor, As Chief Drug Development Officer

NEWS

Interview with Dr. Szilard Voros, Ceo and Co-Founder of Global Genomics Group

Interview with Dr. Szilard Voros, Ceo and Co-Founder of Global Genomics Group

ARTICLES

Global Genomics Group (G3) and Caprion to Partner on Global Study to Identify Cardiovascular Disease Biomarkers and Drug Targets

Global Genomics Group (G3) and Caprion to Partner on Global Study to Identify Cardiovascular Disease Biomarkers and Drug Targets

NEWS

G3, Quintiles Enter Target Discovery Alliance

G3, Quintiles Enter Target Discovery Alliance

NEWS

Global genomics group (g3) completes patient enrollment of discovery cohort in global study ahead of schedule

Global Genomics Group (G3) Completes Patient Enrollment of Discovery Cohort in Global Study Ahead of Schedule

NEWS

Pagination

  • First page « First
  • Previous page ‹ Previous
  • Page 1
  • Current page 2

G3T is translating human biology into revelationary new therapies

Partner with us

Copyright © 2022 by G3T. All rights reserved.
Website Design and Development by Sciad Communications Ltd